We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Accelrys, Inc. (MM) | NASDAQ:ACCL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.51 | 0 | 01:00:00 |
Registration Statement No.
|
33-80341
|
|
Registration Statement No.
|
333-20883
|
|
Registration Statement No.
|
333-56883
|
|
Registration Statement No.
|
333-79577
|
|
Registration Statement No.
|
333-39112
|
|
Registration Statement No.
|
333-54968
|
|
Registration Statement No.
|
333-60532
|
|
Registration Statement No.
|
333-101753
|
|
Registration Statement No.
|
333-120674
|
|
Registration Statement No.
|
333-127884
|
|
Registration Statement No.
|
333-161150
|
|
Registration Statement No.
|
333-168642
|
|
Registration Statement No.
|
333-168656
|
|
Registration Statement No.
|
333-176210
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 33-80341
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-20883
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-56883
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-79577
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-39112
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-54968
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-60532
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-101753
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-120674
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-127884
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-161150
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-168642
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-168656
|
Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-176210
|
Delaware
|
33-0557266
|
(State or other jurisdiction of incorporation or organization
)
|
(I.R.S. Employer Identification No.)
|
5005 Wateridge Vista Drive
San Diego, CA
|
92121-1761
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Large accelerated filer
¨
|
|
Accelerated filer
x
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
(Do not check if a smaller reporting company)
|
|
1. |
Registration Statement No. 333-80341, registering an aggregate of 1,150,000 shares of common stock, par value $0.0001 per share, of the Company (“Common Stock”) under (a) the Pharmacopeia, Inc. (“Pharmacopeia”) 1994 Incentive Stock Plan (the “1994 Plan”), (b) the Pharmacopeia 1995 Director Option Plan (the “1995 Director Plan”) and (c) the Pharmacopeia 1995 Employee Stock Purchase Plan (the “1995 ESPP”), as previously filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 13, 1995;
|
|
2. |
Registration Statement No. 333-20883, registering 1,000,000 shares of Common Stock under the 1994 Plan, as previously filed with the SEC on January 31, 1997;
|
|
3. |
Registration Statement No. 333-56883, registering an aggregate of 2,629,039 shares of Common Stock under (a) the 1994 Plan, (b) the Molecular Simulations Incorporated (“Molecular”) 1988 Stock Option and Purchase Plan, (c) the Molecular 1996 Equity Incentive Plan, (d) the Polygen Corporation (“Polygen”) 1986 Incentive Stock Option Plan, (e) the Polygen 1986 Incentive Stock Option Plan (California), (f) the Polygen 1986 Supplemental Stock Option Plan and (g) the Polygen 1986 Supplemental Stock Option Plan (California), as previously filed with the SEC on June 15, 1998;
|
|
4. |
Registration Statement No. 333-79577, registering 950,000 shares of Common Stock under the 1994 Plan, as previously filed with the SEC on May 28, 1999;
|
|
5. |
Registration Statement No. 333-39112, registering an aggregate of 1,150,000 shares of Common Stock under (a) the 1994 Plan and (b) the 1995 Director Plan, as previously filed with the SEC on June 12, 2000;
|
|
6. |
Registration Statement No. 333-54968, registering 750,000 shares of Common Stock under the Pharmacopeia 2000 Stock Option Plan, as previously filed with the SEC on February 5, 2001;
|
|
7. |
Registration Statement No. 333-60532, registering 500,000 shares of Common Stock under the 1995 ESPP, as previously filed with the SEC on May 9, 2001;
|
|
8. |
Registration Statement No. 333-101753, registering 1,000,000 shares of Common Stock under the 1994 Plan, as previously filed with the SEC on December 10, 2002;
|
|
9. |
Registration Statement No. 333-120674, registering 750,000 shares of Common Stock under the Company’s 2004 New-Hire Equity Incentive Plan, as previously filed with the SEC on November 22, 2004;
|
|
10. |
Registration Statement No. 333-127884, registering an aggregate of 7,229,597 shares of Common Stock under the Company’s (a) Amended and Restated 2004 Stock Incentive Plan and (b) 2005 Employee Stock Purchase Plan (the “2005 ESPP”), as previously filed with the SEC on August 26, 2005;
|
|
11. |
Registration Statement No. 333-161150, registering 800,000 shares of Common Stock under a Stock Option Agreement for a stand-alone inducement award to Scipio “Max” Carnecchia, as previously filed with the SEC on August 7, 2009;
|
|
12. |
Registration Statement No. 333-168642, registering an aggregate of 2,375,532 shares of Common Stock under (a) the Symyx Technologies, Inc. 2007 Stock Incentive Plan, as amended (the “Symyx 2007 Plan”), (b) the Intellichem, Inc. 2003 Stock Option Plan, as amended, (c) the Symyx Technologies, Inc. 2001 Nonstatutory Stock Option Plan, (d) the Synthematix, Inc. Amended and Restated 2000 Equity Compensation Plan and (e) the Symyx Technologies, Inc. 1997 Stock Plan, as amended, as previously filed with the SEC on August 9, 2010;
|
|
13. |
Registration Statement No. 333-168656, registering 7,516,896 shares of Common Stock under the Symyx 2007 Plan, as previously filed with the SEC on August 9, 2010; and
|
|
14. |
Registration Statement No. 333-176210, registering 23,667,296 shares of Common Stock under the Company’s 2011 Stock Incentive Plan, as previously filed with the SEC on August 10, 2011.
|
ACCELRYS, INC.
|
|||
|
By:
|
/s/ Max Carnecchia | |
Max Carnecchia
|
|||
President and Chief Executive Officer | |||
Signatures
|
Title
|
Date
|
||
/s/ Max Carnecchia
|
President and Chief Executive Officer
|
April 29, 2014
|
||
Max Carnecchia | (Principal Executive Officer) | |||
/s/ Michael A. Piraino | Executive Vice President and Chief Financial Officer | April 29, 2014 | ||
Michael A. Piraino
|
(Principal Financial Officer and Principal Accounting Officer)
|
|
||
/s/ Thibault de Tersant |
Director
|
April 29, 2014
|
||
Thibault de Tersant
|
|
|
||
/s/ Bernard Charlès |
Director
|
April 29, 2014
|
||
Bernard Charlès
|
|
|
||
/s/ Deborah Dean | Director |
April 29, 2014
|
||
Deborah Dean
|
|
|
1 Year Accelrys, Inc. (MM) Chart |
1 Month Accelrys, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions